Current Assets

Work in process

Celestica Work in process decreased by 3.3% to $139.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.2%, from $113.60M to $139.90M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026
Parent metricInventories

How to read this metric

An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.

Detailed definition

Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...

Peer comparison

Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.

Metric ID: inv_work_in_progress

Historical Data

6 periods
 Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$106.60M$113.60M$132.70M$154.70M$144.60M$139.90M
QoQ Change+6.6%+16.8%+16.6%-6.5%-3.3%
YoY Change+35.6%+23.2%
% of Inventories6.1%6.4%6.9%7.6%6.6%5.2%
Share Change+0.3pp+0.6pp+0.6pp-0.9pp-1.4pp
Range$106.60M$154.70M
CAGR+24.3%
Avg YoY Growth+29.4%
Median YoY Growth+29.4%
Current Streak2 quarters decline

Frequently Asked Questions

What is Celestica's work in process?
Celestica (CLS) reported work in process of $139.90M in Q1 2026.
How has Celestica's work in process changed year-over-year?
Celestica's work in process increased by 23.2% year-over-year, from $113.60M to $139.90M.
What does work in process mean?
The value of goods currently in the middle of the manufacturing process.